CJC-1295 WITHOUT DAC + IPAMORELIN

Muscle
Building.

Build a stronger training routine, recover consistently, and give your body the nutrition it needs to grow. Explore the growth-hormone pathway and the proposed CJC without DAC + ipamorelin course.

This guide brings the combination, a Sunday–Thursday schedule, and measurable training goals into one plan.

01UNDERSTAND THE COMBINATION

Growth-hormone signals.
A clear training goal.

This guide covers the short-acting compound commonly called CJC-1295 without DAC, or modified GRF(1–29), paired with ipamorelin.

GHRH ANALOGUE

CJC without DAC

Targets the growth hormone–releasing hormone receptor. Confirm that the product is the no-DAC compound named in this guide.

The GHRH signal
GH SECRETAGOGUE

Ipamorelin

Targets the growth hormone secretagogue receptor, also called the ghrelin receptor. Its GH-releasing activity was demonstrated in foundational research.

A second receptor pathway

Keep the product and the goal specific.

The commonly cited human CJC-1295 hormone trial used the long-acting with-DAC compound. The course below concerns the no-DAC combination; the two schedules are not interchangeable.

02BUILD PROGRESS YOU CAN MEASURE

Strength.
Recovery. Consistency.

A useful muscle-building plan gives you clear markers to follow from week to week.

01

Stronger performance

Track repetitions and resistance on a few consistent exercises. Progress with good technique gives you something concrete to evaluate.

02

A steady recovery routine

Log sleep, soreness, and how ready you feel for the next session. Adjust training load when recovery is falling behind.

03

Changes over time

Use average body weight, measurements, and consistent photos alongside performance. Judge the trend over weeks.

03PROPOSED COURSE · FOR CLINICAL REVIEW

Eight weeks on.
Eight weeks off.

The example uses Sunday through Thursday, followed by Friday and Saturday off, during weeks 1–8. A full eight-week break follows.

The exact combination’s muscle-building effect and dosing regimen have not been established in controlled human trials. The amounts below are a reference range for clinical review, not instructions to select or increase a dose.

CJC-1295 · WITHOUT DAC100–300 mcg

On each scheduled day in the example

IPAMORELIN100–300 mcg

On each scheduled day in the example

Each range is for the individual compound, not the combined total. mcg = micrograms. The reference uses subcutaneous administration in the evening; a clinician must determine the actual dose and suitability.

Five days on. Two days off.

This weekly pattern applies only during the eight-week course.

  1. SundayOnScheduled day
  2. MondayOnScheduled day
  3. TuesdayOnScheduled day
  4. WednesdayOnScheduled day
  5. ThursdayOnScheduled day
  6. FridayOffNo dose
  7. SaturdayOffNo dose
WEEKS 1–8

8-week course

Sunday–Thursday in the evening.
Friday & Saturday off each week.

WEEKS 9–16

8-week break

Neither compound during the break.

TIMING IN THE EXAMPLE

Evening / before sleep

The proposed routine places scheduled doses in the evening. Follow the timing agreed with your clinician.

Use the break to review the course

Compare training performance, measurements, sleep, and symptoms with your starting point.

Keep your foundations consistent

Continue training, nutrition, and recovery habits. Review the response before deciding on another course; the break is not a proven receptor reset.

The dose range and course length come from the supplied GH Peptides Overview. The weekly example uses five scheduled days and two days off.

04BUILD THE FOUNDATIONS

Give muscle
a reason to grow.

Progressive resistance training, adequate protein and energy, and consistent recovery belong at the center of a muscle-building plan.

Organize the training plan.

Use your experience, equipment, available days, and mobility to build a routine you can repeat. Keep a short training log so each week has a clear purpose.

See planning prompts
05INDIVIDUAL CARE

Track progress.
Monitor your response.

Review the exact product, health history, medications, and monitoring with qualified care. Peptide quality and immune reactions require attention.

Review the starting point

Discuss glucose control, IGF-1, cancer history, and existing swelling or nerve symptoms. Avoid experimental use during pregnancy or breastfeeding.

Act on symptoms

Report new swelling, persistent tingling, palpitations, or dizziness. Increased heart rate and systemic reactions have been reported with CJC-1295.

Chest pain, fainting, or difficulty breathing needs urgent care.

Injection-site comfort

How and where to inject: the illustrated subcutaneous guide.

Itching, redness, or mild swelling can occur after injections. A clean, cool compress can help with mild local discomfort. Seek advice if symptoms persist.

Biofreeze Professional spray is for muscle and joint pain. Its label excludes wounded or irritated skin; it is not recommended here for injection-site itching.

Spreading redness, heat, worsening pain, or fever needs prompt assessment. Trouble breathing, facial swelling, or fainting requires emergency care.